Whats New

Shanghai going all out to become preferred global investment place

2024-04-03

The 2024 Shanghai Global Investment Promotion Conference has once again boosted the confidence of overseas and domestic enterprises who plan to invest in Shanghai.
New quality productive forces to power Shanghai's development

2024-04-02

New quality productive forces and further opening-up will serve as two major engines for Shanghai's high-quality economic growth, said officials of the Shanghai municipal government.
Shanghai hosts business promotion conference for Eastern Hub

2024-03-29

A business promotion conference for the upcoming Shanghai East Railway Station was held at the Lujiazui International Accounting Center in Pudong New Area on March 25.
Shanghai FTZ Global Hub welcomes 4 new national pavilions

2024-03-29

On March 26, the Shanghai FTZ Global Hub in the Shanghai Waigaoqiao Free Trade Zone unveiled four new national pavilions for Hungary, Pakistan, Mongolia, and Armenia.
Shanghai opens more roads for self-driving car tests

2024-03-27

The second batch of autonomous driving test roads in Pudong New Area opened March 19, with the testing mileage reaching 205 kilometers.
Shanghai's Waigaoqiao Port reports growth in auto exports in Jan-Feb

2024-03-22

Shanghai's Waigaoqiao Port completed 138 voyages for foreign trade roll-on/roll-off vessels, exporting 170,200 cars in the first two months of this year, marking a 3 percent increase compared to last year, according to official data.
Nation to grant FDI greater access to its markets

2024-03-21

China will further shorten the negative list for foreign investment and implement pilot programs to ease access for global companies in the fields of scientific and technological innovation, said an action plan released by the General Office of the State Council, China's Cabinet, on Tuesday.
Shanghai marks milestone with first locally developed CAR-T product approval

2024-03-20

Kaixing Life Technology (Shanghai) Co Ltd's CAR-T product, Zevor-cel (CT053), designed for treating relapsed or refractory multiple myeloma in adults, has received market approval from the National Medical Products Administration.

< 1 ... 8 9 10 11 12 ... 108 >

What's New